CESAR LINARES ALTAMIRANO Q1-2026 supplier risk profile: 81 shipments, 2 sources, China & India.
CESAR LINARES ALTAMIRANO imported 81 shipments in Q1 2026 from 2 suppliers across 2 countries. China supplied 60% of shipments (49 total), led by CHANGSHA MEDLAB INSTRUMENT. India accounted for the remaining 40% via TITAN BIOTECH. The import profile is dominated by HS Chapter 38 (miscellaneous chemical products), which represented the largest single commodity category across the sourcing mix.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
No sanctions watchlist matches were identified for this importer. No suppliers in the sourcing network registered exposure to forced-labor concerns under UFLPA proximity screening.
2 distinct tier-1 suppliers in Q1 2026
| CHANGSHA MEDLAB INSTRUMENT | China | 49 |
| TITAN BIOTECH | India | 32 |
Share of Q1 2026 inbound shipments by source country
4 tier-2 + 1 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.